Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity
Clinical trial NCT00000977 · COMPLETED
Trial details
- NCT number
- NCT00000977
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.